Article Details

Quest Announces that OncoQuest Pharmaceuticals Inc. Doses First Patient in Phase 3 Clinical ...

Retrieved on: 2020-11-09 06:30:00

Tags for this article:

Click the tags to see associated articles and topics

Quest Announces that OncoQuest Pharmaceuticals Inc. Doses First Patient in Phase 3 Clinical .... View article details on hiswai:

Excerpt

<div>Oregovomab is a murine IgG <b>monoclonal antibody</b> against CA 125. ... Ltd. OncoQuest Pharmaceuticals' next-generation <b>monoclonal antibodies</b> are ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up